5-ALA (5-aminolevulinic acid) is a naturally occurring compound that the body already makes as a step in building haem, and Japan turned it into a fermentation-produced food ingredient. Brands abroad ask about it because of that Japanese origin, and because it is now backed by a small but growing set of human trials.
This guide covers what those trials found, how Japanese regulators frame the ingredient, and one distinction every brand needs to keep straight: 5-ALA also exists as a very different, much higher-dose medical product in some markets, and the two should never be confused on a label.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a 5-ALA product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
A small number of manufacturer-funded randomised trials report improvements in everyday fatigue, mood and exercise-related antioxidant balance, but independent replication is still limited.
| Study | Design/What was analysed | Reported result |
|---|---|---|
| RCT, Scientific Reports 2020 (PMID 32994490) | 70 healthy adults aged 20–64 with everyday physical tiredness; 30 mg 5-ALA phosphate plus 34.5 mg sodium ferrous citrate daily vs placebo, 8 weeks | Overall fatigue and work-related fatigue scores (VAS) fell significantly more than placebo; the Anger-Hostility mood subscale also improved |
| RCT, International Journal of Molecular Sciences 2024 (PMID 38256062) | 14 healthy adults aged 20–40, crossover design; 25 mg 5-ALA plus 29 mg sodium ferrous citrate daily vs placebo, 4 weeks | Antioxidant balance markers improved during high-intensity exercise; heart rate, lactate and other aerobic-capacity measures were unchanged |
| RCT, Geriatrics 2018 (PMID 29862247) | 154 adults aged 41–71 with prediabetes; 15 mg or 50 mg 5-ALA daily vs placebo, 12 weeks | Coping-ability and self-perceived-effort scores improved versus placebo, with a larger effect at the higher dose |
All three trials were funded by, or used study material supplied by, the same ingredient manufacturer, and two of the three enrolled fewer than 75 people. The Geriatrics trial enrolled adults with prediabetes, a population outside this guide’s healthy-ageing framing, so its result should not be read as evidence for people without that condition. Independently funded, larger-scale trials have not yet confirmed these findings.
Checked against the published abstracts on 25 September 2026.
What Japanese products say
5-ALA has been notified in Japan’s Foods with Function Claims system for everyday functions such as fatigue and vitality, and this food-grade ingredient is a different product from the much higher-dose form used in medical procedures.
Under Japan’s Foods with Function Claims system, the notifying business is responsible for the scientific evidence behind the stated function, submitted to the Consumer Affairs Agency before sale. Notified functions for 5-ALA include everyday tiredness, vitality and related wellbeing states, described in modest, non-medical wording.
Separately, 5-ALA is also used — in Japan and some other markets — as a prescription medicine and diagnostic agent, most often to help visualise tumour tissue during surgery under a photodynamic procedure. That medical use is dosed by body weight, commonly around 20 mg per kilogram, which for an average adult works out to roughly a thousand milligrams in a single dose. That is more than twenty times the 15–50 mg per day used in the dietary trials above. The food-grade ingredient and the medical product share a chemical identity but differ in dose, regulatory pathway and purpose, and a food-grade 5-ALA product should never be described using the medical use or its indications.
💬 Need an evidence summary for your regulatory adviser that keeps the dietary ingredient and the medical use clearly separated? We prepare it with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe 5-ALA by what has been studied in dietary trials, and keep the medical use out of the picture entirely.
| Safer wording | Wording to avoid |
|---|---|
| ”Contains 5-ALA, studied for everyday tiredness” | Names of diseases, or “treats” anything |
| ”A fermentation-derived ingredient, studied at 15–50 mg per day” | Any reference to photodynamic procedures, tumour visualisation or surgery |
| ”Studied for antioxidant balance during exercise" | "Clinically proven” without naming the study and its limits |
How 5-ALA is formulated
5-ALA is water-soluble and dosed in single-digit to double-digit milligrams, usually paired with an iron source, which keeps it compatible with tablets, capsules and drink formats.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Tablet | Common, easy dosing at a small serving size | Stability of the blend with other actives |
| Hard capsule | Simple, flavourless | Suits combined formulas |
| Powder stick / drink | Fits a daily routine format | Taste and colour stability |
Decisions that shape the specification:
- Source. 5-ALA used in foods is produced by fermentation. Ask the supplier for the production method, the salt form (commonly a phosphate salt) and the certificate of analysis.
- Amount per serving. Published trials used 15–50 mg per day; match the amount to any study you intend to cite.
- Companion ingredients. 5-ALA is frequently paired with an iron source such as sodium ferrous citrate, since iron is needed for the next step in the body’s own haem pathway. Every companion ingredient needs its own check against Japanese food law.
- Your market’s status for 5-ALA. Its status as a food or dietary supplement ingredient differs between countries, and some markets treat it, or ingredients related to it, more cautiously because of its separate medical use. Confirm the status before you commit to a formula.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
5-ALA itself is registered for use in Japanese foods, but any companion ingredient in an energy or healthy-ageing formula needs the same check, and the medical/food distinction above needs to be reflected correctly in your dossier. See the Japan-made supplement OEM page, and compare with our CoQ10 and NMN guides for two other healthy-ageing ingredients with their own evidence and regulatory questions.
Before you ask for a quotation
A factory can quote accurately once the amount, the form, the companions and the packaging are fixed.
- 5-ALA amount per serving and servings per pack
- Dosage form, and any companion ingredients (such as an iron source) and their amounts
- Packaging and stability requirements
- Countries you will sell in, and 5-ALA’s status there
- First order and annual volume
💬 Ready to design a Japan-made 5-ALA product? Send us the concept — amount, form, companion ingredients and the countries you will sell in.
Frequently asked questions
1. Is there strong evidence that 5-ALA reduces fatigue?
A small randomised trial in 70 healthy adults found a significant reduction in fatigue and improved mood scores over 8 weeks. The trial was funded by the ingredient manufacturer and has not yet been independently replicated at scale.
2. Is 5-ALA the same thing as the drug used in cancer surgery?
It is chemically related but a different product. The medical use is dosed by body weight, commonly around 20 mg per kilogram — far above the 15–50 mg per day used in dietary trials. A food-grade 5-ALA product should never be described using the medical use.
3. What form is 5-ALA usually sold in for foods?
Most commonly a phosphate salt, paired with an iron source such as sodium ferrous citrate, in tablets, capsules or drink formats.
4. Why is 5-ALA so often combined with iron?
5-ALA is a step in the body’s own pathway for building haem, which needs iron for the following step. Studies pairing the two have used amounts such as 25–34.5 mg of an iron source alongside the 5-ALA.
5. What can stop a Japanese factory making my 5-ALA product?
Usually a companion ingredient that Japan treats differently from your home market, or wording in your concept that leans on the medical use of 5-ALA. We check the full formula and the proposed wording first.
Sources: “Reduction of fatigue and anger-hostility by the oral administration of 5-aminolevulinic acid phosphate: a randomized, double-blind, placebo-controlled, parallel study”, Scientific Reports 2020 (PMID 32994490); “The Impact of 5-Aminolevulinic Acid Supplementation on Redox Balance and Aerobic Capacity”, International Journal of Molecular Sciences 2024 (PMID 38256062); “The Relationship of 5-Aminolevulinic Acid on Mood and Coping Ability in Prediabetic Middle Aged and Older Adults”, Geriatrics 2018 (PMID 29862247); “Randomized, Prospective Double-Blinded Study Comparing 3 Different Doses of 5-Aminolevulinic Acid for Fluorescence-Guided Resections of Malignant Gliomas” (PMC5808499); Consumer Affairs Agency notifications for Foods with Function Claims. Checked on 25 September 2026.